Report overview
Female Infertility Drugs?are usually prescribed to?women?as they're mostly used to help with ovulation problems.
This report contains market size and forecasts of Female Infertility Drugs in global, including the following market information:
Global Female Infertility Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Female Infertility Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Female Infertility Drugs companies in 2021 (%)
The global Female Infertility Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Parenteral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Female Infertility Drugs include Allergan Plc, Ferring BV, Merck KGaA, Novartis AG and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Female Infertility Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Female Infertility Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Infertility Drugs Market Segment Percentages, by Type, 2021 (%)
Parenteral
Oral
Others
Global Female Infertility Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Infertility Drugs Market Segment Percentages, by Application, 2021 (%)
Fertility Clinics
Hospitals
Cryobanks
Global Female Infertility Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Female Infertility Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Female Infertility Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Female Infertility Drugs revenues share in global market, 2021 (%)
Key companies Female Infertility Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Female Infertility Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Ferring BV
Merck KGaA
Novartis AG
Sanofi
